Hosts Dr. Matt Birnholz and Dr. Michael Greenberg talk to Dr. Sanjiv Chopra, faculty dean of continuing medical education at Harvard Medical School and co-author of the book Doctor Chopra Says: Medical Facts & Myths Everyone Should Know, about medical research that changes so fast even physicians can't keep up. And, "Jeopardy!" contestant Ken Jennings said that he, for one, welcomed "our new computer overlords." What about a computer physician's assistant? Dr. Birnholz caught up with Dr. Herbert Chase, professor of clinical medicine in biomedical informatics at Columbia University College of Physicians and Surgeons, who is teaching IBM's "Watson" computer how to help doctors. Plus: Bodily fluids in the news.
Facts, Myths, and Computer Overlords
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Hosts Dr. Matt Birnholz and Dr. Michael Greenberg talk to Dr. Sanjiv Chopra, faculty dean of continuing medical education at Harvard Medical School and co-author of the book Doctor Chopra Says: Medical Facts & Myths Everyone Should Know, about medical research that changes so fast even physicians can't keep up. And, "Jeopardy!" contestant Ken Jennings said that he, for one, welcomed "our new computer overlords." What about a computer physician's assistant? Dr. Birnholz caught up with Dr. Herbert Chase, professor of clinical medicine in biomedical informatics at Columbia University College of Physicians and Surgeons, who is teaching IBM's "Watson" computer how to help doctors. Plus: Bodily fluids in the news.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
Partnering with Patients: Building Effective Communication and Support in HF Care
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?